Event Information

Partner Alan Johnson, is a panellist at C5’s Pharma and Biotech Patent Litigation conference in Amsterdam on 14-15 March. He will be discussing the UPC together with other Unitary Patent Advisory committee members
C5’s 8th Pharma & Biotech Patent Litigation conference will provide an invaluable focus for analysis of all the fundamental changes affecting pharma and biotech patents across Europe and the US and consider the impact of judicial decisions in the national courts on your litigation strategies.
To find out more or to register your place, please click HERE.